← Leaderboards
Meghan Norvell
Azano Pharmaceuticals, Inc.
$146,716
Attributed
$146,716
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$146,716 · 1
By mechanism
R43$146,716 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAdverse EffectsAffectAnimalsAntigen-Antibody ComplexAttenuatedAutoimmune DiseasesBaseBinding (Molecular Function)Biological Response Modifier TherapyBody SystemChronicC-Reactive ProteinCystitisCytotoxicDepositionDiagnosisDoseDrug CandidateDrug EfficacyEarly TreatmentEffector CellEnd Stage Renal FailureAchievement